Quotables
"There is no reason anyone would want a computer in their home."
Ken Olsen, chairman and founder of Digital Equipment Corporation ; 1977
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120130302 | ACTIVE RETINAL IMPLANT An active retinal implant (10) to be implanted into an eye has an array (16) of stimulation elements (17) that emit stimulation signals to cells of the retina, wherein the stimulation elements (17) are designed as radiation-emitting elements.... | 05/24/2012 |
| 20120130303 | RATE CONTROL DURING AF USING CELLULAR INTERVENTION TO MODULATE AV NODE A biologic intervention method and apparatus generates a persistent modification to an AV node that is physiologically stable after the agent has matured but is alterable with subsequent application of an agent. Specifically, the generic agent is used to modulate a node... | 05/24/2012 |
| 20120107242 | NUCLEIC ACID-MEDIATED SHAPE CONTROL OF NANOPARTICLES FOR BIOMEDICAL APPLICATIONS Embodiments of a method for nucleic acid-mediated control of a nanoparticle shape are disclosed. In some embodiments, one or more nucleic acid oligomers are adsorbed to a metal nanoseed, and additional metal is deposited onto the nanoseed to produce a shaped nanoparticl... | 05/03/2012 |
| 20120109042 | Methods of Treating Diseased Tissue Two or three external therapeutic options such as clobetasol propionate spray, calcitriol ointment, and excimer laser phototherapy are used to treat generalized psoriasis with systemic safety and better efficacy than any systemic or biologic agent. Combinations of these... | 05/03/2012 |
| 20120109041 | APPLICATOR DEVICE FOR COSMETIC AND/OR MEDICAL USE The invention relates to an applicator device, comprising an applicator element (9) for applying a substance (27) present in a substance chamber (25, 27) to a skin section. The applicator device (1) comprises an applicator part (2) hav... | 05/03/2012 |
| 20120109043 | Integrated skin-treatment specimen dispenser A device for skin treatment by concurrently applying a series of physical movement such as ultrasound vibration and dispensing a specimen to a target kin area is disclosed. The device includes a skin treatment surface for treating the target skin area, a cartridge conta... | 05/03/2012 |
| 20120108880 | CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS Tumor suppressor genes play a major role in the pathogenesis of human lung cancer and other cancers. Cytogenetic and allelotyping studies of fresh tumor and tumor-derived cell lines showed that cytogenetic changes and allele loss on the short arm of chromosome 3 (3p) ar... | 05/03/2012 |
| 20120082621 | SWALLOWTAIL MOTIFS FOR IMPARTING WATER SOLUBILITY TO PORPHYRINIC COMPOUNDS Porphyrinic compounds that contain solubilizing groups are described, along with methods of making and using the same and compositions comprising such compounds. Examples of such compounds include compounds compounds of Formula I: | 04/05/2012 |
| 20120071810 | PHOTODYNAMIC THERAPY INCLUDING LIGHT PRETREATMENT A method of photodynamic therapy is described that includes administering a therapeutically effective amount of a photosensitizer to an area of tissue such as the skin of a subject, delivering a first photoirradiation with light having a wavelength suitable to activate ... | 03/22/2012 |
| 20120071811 | STIMULATION METHOD FOR THE SPHENOPALATINE GANGLIA, SPHENOPALATINE NERVE, OR VIDIAN NERVE FOR TREATMENT OF MEDICAL CONDITIONS A method is provided for suppressing or preventing pain in a patient. One step of the method includes positioning first and second electrodes, without penetrating the cranium, on or proximate to at least one of the sphenopalatine ganglia, the sphenopalatine nerves, or t... | 03/22/2012 |
| 20120071478 | SUBSTITUTED BENZOTRIAZINES AND QUINOXALINES AS INHIBITORS OF P7OS6 KINASE The invention provides compounds of the formula (1): or salts or tautomers thereof; wherein X1 is N or N+(O−); X2 is N or CH; Q is a C1-3 alkylene grou... | 03/22/2012 |
| 20120071704 | MITOCHONDRIAL LOCALIZATION OF MUC1 The invention provides methods of identifying and making compounds that inhibit the interaction between MUC1 and either or both of HSP70 and HSP90. Also embraced by the invention are in vivo and in vitro methods of inhibiting such an interaction.... | 03/22/2012 |
| 20120053511 | Compounds Containing Acyclic N-N Bonds for Phototherapy The invention relates generally to optical agents for biomedical applications, including phototherapy. The invention includes optical agents, and related therapeutic methods, comprising compounds with an acyclic N—N bond having at least one aromatic and/or heterocycli... | 03/01/2012 |
| 20120053508 | THERAPY FOR RAPID EYE MOVEMENT BEHAVIOR DISORDER (RBD) Examples for delivering electrical stimulation to a patient via a medical device to manage or treat rapid eye movement behavior disorder (RBD) are described. In one example, a method comprises determining a patient is in a rapid eye movement (REM) sleep stage, and deliv... | 03/01/2012 |
| 20120053509 | VACCINES FOR HUMAN PAPILLOMA VIRUS AND METHODS FOR USING THE SAME Improved anti-HPV immunogens and nucleic acid molecules that encode them are disclosed. Immunogens disclosed include those having consensus HPV 6, HPV 11, HPV 33 and HPV58 E6 and E7. Pharmaceutical composition, recombinant vaccines comprising and live attenuated vaccine... | 03/01/2012 |
| 20120053507 | IMPLANTABLE ELECTRONIC THERAPY DEVICE An implantable electronic therapy device, having a therapy unit, a heart rate capturing unit, a contractility determination unit, and an evaluation and control unit. The therapy unit delivers an antitachycardiac therapy. The heart rate capturing unit determines a ventri... | 03/01/2012 |
| 20120053510 | Treatment of Cardiac Arrhythmia by Modification of Neuronal Signaling Through Fat Pads of the Heart To control cardiac arrhythmias such as atrial fibrillation post-operatively, various non-ablative agents include polymers, fibroblasts, neurotoxins, and growth factors are introduced into one or more cardiac fat pads into the atrioventricular nodal fat pad in proximity ... | 03/01/2012 |
| 20120053512 | UV-C ANTIMICROBIAL DEVICE FOR INTRAVENOUS THERAPY A vascular access device having a fluid chamber in which UV-C radiation is emitted to irradiate pathogens contained in an infusate flowing though the fluid chamber.... | 03/01/2012 |
| 20120046597 | ELECTRODE ARRANGEMENT FOR GENERATING A NON-THERMAL PLASMA The invention relates to an electrode arrangement (1) for generating a non-thermal plasma, comprising: a layer-shaped first electrode (2) made of an electrically conductive material, a layer-shaped second electrode (4) made of an electrically conduc... | 02/23/2012 |
| 20120046598 | Contactless Electropermeabilization Electrode and Method Devices and methods for delivering an electropermeabilizing pulse of electric energy to a tissue surface to enable delivery into cells in the tissue therapeutic substances. The device incorporates a source capable of generating a sufficient voltage potential to deliver ... | 02/23/2012 |
| 20120041356 | PHOTODYNAMIC THERAPY FOR CONDITIONS OF THE EYE The use of a combination of photodynamic therapy and an anti-VEGF agent in the treatment of conditions characterized by unwanted choroidal neovasculature is described. These conditions include wet age-related macular degeneration Preferred anti-VEGF agents are antibodie... | 02/16/2012 |
| 20120041357 | METHOD OF CONTROLLED DRUG RELEASE FROM A LIPOSOME CARRIER Disclosed are methods and compositions for the controlled release of a drug or agent from a liposome using light or radiation. Also disclosed are compositions comprising liposomes having a lipid layer, wherein the liposomes contain an agent, an enzyme capable of releasi... | 02/16/2012 |
| 20120041306 | CONTRAST AGENT ADMINISTRATION METHOD AND SYSTEM TO MAINTAIN CONTRAST AGENT AT A LOCALIZED SITE OF DELIVERY In a method and system for administering a dispersible medical agent to a subject, a volume of medical agent is delivered in vivo to a subject in a substantially non-dispersed state, at a localized site in tissue of the subject. Contemporaneously with administration of ... | 02/16/2012 |
| 20120041355 | MULTIPLE SECTION PARENTERAL DRUG DELIVERY APPARATUS The invention relates to a parenteral therapeutic agent delivery device. The therapeutic agent delivery device has a disposable section and an implant section suitable for long term implantation within the tissue of a subject. When necessary, the disposable section can ... | 02/16/2012 |
| 20120035511 | SYSTEM AND METHODS OF TREATMENT USING ELECTROMAGNETIC ILLUMINATION A method of inducing local cell death in patient tissue is provided. The method includes generating first and second radiation, conveying the radiation to a focusing element, and focusing the radiation on a target with the focusing element. A system for inducing local c... | 02/09/2012 |
| 20120035529 | TUMOR VASCULAR MARKER-TARGETED VACCINES The present invention provides methods of immunizing a subject against a tumor, inhibiting tumor growth, inhibiting tumor recurrence, treating, suppressing the growth of, or decreasing the incidence of a tumor, overcoming tolerance to a tumor vasculature marker (TVM) in... | 02/09/2012 |
| 20120035527 | PHOTOCHEMICAL TISSUE BONDING The exemplary embodiments of the present invention provides exemplary methods for adhering biological membranes to luminal anatomical structures using photosensitizing agents and electromagnetic energy. The exemplary embodiments of the present invention also provides me... | 02/09/2012 |
| 20120035528 | LOW-PERMEABILITY, LASER-ACTIVATED DRUG DELIVERY DEVICE An implantable drug delivery device that uses multiple reservoir elements to contain and release doses of active pharmaceutical ingredients. The device includes a first shell element, which has a first enclosed cavity volume and forms a low-permeability barrier. The fir... | 02/09/2012 |
| 20120029418 | COMPOSITION AND METHOD FOR PHOTODYNAMIC DISINFECTION The present invention includes a composition for photoablation comprising a photosensitizer and ethylenediaminetetraacetic acid (“EDTA”) at a very low concentration (e.g., ranging from about 0.01 mM to about 1.25 mM), wherein the composition is used for photoablatio... | 02/02/2012 |
| 20120029419 | TREATING CANCER USING ELECTROMAGNETIC FIELDS IN COMBINATION WITH OTHER TREATMENT REGIMENS Chemotherapeutic treatment for certain cancers may be combined with low intensity, intermediate frequency alternating electric fields that are tuned to a particular type of target cell. When the tuned fields were combined with Paclitaxel, Doxorubicin or Cyclophosphamide... | 02/02/2012 |
| 20120029420 | COMBINATION AND ELEECTRICAL STIMULATING AND INFUSION MEDICAL DEVICE AND METHOD A combined electrical and chemical stimulation lead is especially adapted for providing treatment to the spine and nervous system. The stimulation lead includes electrodes that may be selectively positioned along various portions of the stimulation lead in order to prec... | 02/02/2012 |
| 20120029417 | COSMETIC TREATMENT METHOD INCLUDING THE PROJECTION OF AN IMAGE ONTO THE ZONE TO BE TREATED A treatment method for treating human keratinous material, the method including: a) projecting an image onto a zone to be treated; b) modifying the content and/or adjusting the projected image; and c) cosmetically treating the zone as a function of the image as modified... | 02/02/2012 |
| 20120029416 | POROUS ELECTROACTIVE HYDROGELS AND USES THEREOF The present invention provides porous electroactive hydrogels, the deformation angle of which is controlled by electroactuation, and methods for preparing and using such hydrogels.... | 02/02/2012 |
| 20120022433 | METHODS FOR INCREASING TRICHOGENICITY OF DERMAL CELLS Methods for increasing trichogenic activity of populations of dermal cells by inducing local trauma to skin tissue that serves as a source of the dermal cells are provided. Methods for obtaining dermal cells with increased trichogenic activity and for using the disclose... | 01/26/2012 |
| 20120022432 | GAS MIST PRESSURE BATHING SYSTEM The present invention is to provide a gas mist pressure bathing system enabling to cause a gas mist to be absorbed into the skin and the mucous membrane of the living organism under an optimum condition of controlling the amounts of gas and liquid. The system comprises ... | 01/26/2012 |
| 20120022431 | Iontophoretic Drug Delivery Packaging The present invention relates generally to iontophoretic drug delivery systems for transdermal delivery of therapeutic agents and, more particularly, to packaging such systems for long shelf life and easy assembly for use. The system package includes an iontophoretic sk... | 01/26/2012 |
| 20120016289 | ARTICLES, COMPOSITIONS, AND METHODS FOR KILLING OR PREVENTING THE GROWTH OF MICROBES Described herein are methods and compositions for killing or preventing the growth of microbes. It has been discovered that a class of porphyrins can kill or prevent the growth of microbes. The porphyrins can be used in a number of different applications where microbes ... | 01/19/2012 |
| 20120016290 | LED-BASED SKIN TREATMENT SYSTEM AND METHOD Provided are an LED-based skin treatment system capable of performing a skin treatment in consideration of individuals' respective skin properties and a reaction of skin to a change in a patient's emotional state by using an LED light source, and a method thereof. The L... | 01/19/2012 |
| 20120015331 | SCAFFOLD The present invention provides a polymeric scaffold containing an antibacterial photoactive drug and optionally comprising seeded cells such as stem cells. The invention also includes methods of using the scaffold for tissue regeneration, prevention or reduction of infe... | 01/19/2012 |
| 20120009539 | Intraoral Light-Emitting Device The present invention relates to methods, systems, kits and devices that emit light to the oral cavity. The device includes a light source; a power source in electrical communication with the light source; and a bite actuated switch in electrical communication with the ... | 01/12/2012 |
